Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 193.02M | 186.82M | 160.12M | 141.57M | 119.06M | 102.03M |
Gross Profit | 50.20M | 48.57M | 42.44M | 26.79M | 28.71M | 26.93M |
EBITDA | 19.68M | 17.46M | 20.20M | 5.08M | 8.61M | 8.19M |
Net Income | 10.61M | 9.03M | 11.37M | 924.00K | 3.31M | 3.23M |
Balance Sheet | ||||||
Total Assets | 98.27M | 90.55M | 81.65M | 69.00M | 70.87M | 60.07M |
Cash, Cash Equivalents and Short-Term Investments | 21.22M | 16.73M | 13.20M | 4.44M | 9.23M | 7.93M |
Total Debt | 220.00K | 117.00K | 2.92M | 6.68M | 7.46M | 3.11M |
Total Liabilities | 19.57M | 18.64M | 21.22M | 21.43M | 21.74M | 13.21M |
Stockholders Equity | 78.70M | 71.91M | 60.44M | 47.57M | 49.13M | 46.85M |
Cash Flow | ||||||
Free Cash Flow | 1.32M | 6.26M | 12.59M | 538.00K | 3.64M | 4.49M |
Operating Cash Flow | 8.63M | 12.96M | 16.94M | 3.99M | 5.56M | 6.38M |
Investing Cash Flow | -1.98M | -6.68M | -4.41M | -4.03M | -7.14M | -1.89M |
Financing Cash Flow | -65.00K | -2.75M | -3.78M | -4.75M | 2.88M | -405.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | 293.10M | 22.28 | 8.95% | ― | 4.33% | -6.33% | |
75 Outperform | 443.46M | 95.72 | 15.29% | ― | 19.34% | -12.64% | |
64 Neutral | $404.87M | 38.33 | 14.46% | ― | 9.19% | -23.91% | |
60 Neutral | 720.94M | -102.01 | -11.71% | ― | 10.90% | 96.02% | |
47 Neutral | 148.98M | -0.28 | -111.75% | ― | -10.17% | -609.02% | |
42 Neutral | 66.76M | -59.96 | -13.79% | ― | 22.79% | 74.00% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
On September 2, 2025, Lifeway Foods announced estimated unaudited net sales of $39.1 million for the first two months of the third quarter, marking a 20% increase from the previous year. This growth highlights the company’s strong market position and increasing consumer demand for its kefir and high-protein cheese products, reinforcing its leadership in the probiotic nutrition sector.
The most recent analyst rating on (LWAY) stock is a Buy with a $33.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.
Lifeway Foods reported record financial results for the second quarter of 2025, with net sales reaching $53.9 million, marking an 18% increase on a comparable basis. The company also announced a strong start to the third quarter with estimated net sales of $26.4 million through August 11, 2025, reflecting a 20% year-over-year growth. This performance underscores Lifeway’s leadership in the kefir category and its ability to capitalize on consumer trends towards wellness and probiotic foods. The company was recognized as Processor of the Year by Dairy Foods magazine, highlighting its innovation and impact in the dairy industry.
The most recent analyst rating on (LWAY) stock is a Buy with a $28.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.
On July 29, 2025, Lifeway Foods announced that Institutional Shareholder Services Inc. (ISS) recommended shareholders not support the dissident-led consent solicitation. ISS found the dissident group’s case for change unconvincing, citing Lifeway’s positive financial performance and lack of a clear plan from the dissidents. The recommendation supports Lifeway’s management, who believe the solicitation is disruptive and not in shareholders’ best interests.
The most recent analyst rating on (LWAY) stock is a Buy with a $28.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.